Ledger.Open graph →
SEC Form D · filed December 23, 2021

EIP Pharma, Inc

Offering
$10.0M
Sold
$6.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Boston, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Frank Zavrl · Cambridge, MADirectorMarwan Sabbagh · Boston, MADirectorSylvie Gregoire · WALTHAM, MAExec · DirectorJeff Poulton · Cambridge, MADirectorJohn Alam · Cambridge, MAExec · DirectorFrank Zavrl · Cambridge, MADirectorMarwan Sabbagh · Boston, MADirectorSylvie Gregoire · WALTHAM, MAExec · DirectorJeff Poulton · Cambridge, MADirectorJohn Alam · Cambridge, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗